| Year |
Citation |
Score |
| 2022 |
Agosto-Burgos C, Wu EY, Iannone MA, Hu Y, Hogan SL, Henderson CD, Kennedy KB, Blazek L, Herrera CA, Munson D, Falk RJ, Ciavatta DJ, Free ME. The frequency of Treg subsets distinguishes disease activity in ANCA vasculitis. Clinical & Translational Immunology. 11: e1428. PMID 36381498 DOI: 10.1002/cti2.1428 |
0.742 |
|
| 2022 |
Chen D, McInnis E, Wu E, Stember K, Hogan S, Hu Y, Henderson C, Blazek L, Mallal S, Karosiene E, Peters B, Sidney J, James E, Kwok W, Jennette JC, ... ... Falk R, et al. Immunological Interaction of HLA-DPB1 and Proteinase 3 in ANCA Vasculitis is Associated with Clinical Disease Activity. Journal of the American Society of Nephrology : Jasn. PMID 35672132 DOI: 10.1681/ASN.2021081142 |
0.739 |
|
| 2022 |
Massicotte-Azarniouch D, Herrera CA, Jennette JC, Falk RJ, Free ME. Mechanisms of vascular damage in ANCA vasculitis. Seminars in Immunopathology. PMID 35254509 DOI: 10.1007/s00281-022-00920-0 |
0.754 |
|
| 2020 |
Jones BE, Herrera CA, Agosto-Burgos C, Starmer J, Bass WA, Poulton CJ, Blazek L, Henderson CD, Hu Y, Hogan SL, Hu P, Xiao H, Wu EY, Chen DP, Jennette JC, ... ... Falk RJ, et al. ANCA autoantigen gene expression highlights neutrophil heterogeneity where expression in normal-density neutrophils correlates with ANCA-induced activation. Kidney International. PMID 32446935 DOI: 10.1016/J.Kint.2020.04.037 |
0.745 |
|
| 2019 |
Mendoza CE, Brant EJ, McDermott ML, Froment A, Hu Y, Hogan SL, Jennette JC, Falk RJ, Nachman PH, Derebail VK, Bunch DO. Elevated Microparticle Tissue Factor Activity Differentiates Patients With Venous Thromboembolism in Anti-neutrophil Cytoplasmic Autoantibody Vasculitis. Kidney International Reports. 4: 1617-1629. PMID 31891003 DOI: 10.1016/J.Ekir.2019.07.006 |
0.344 |
|
| 2019 |
Hu P, Su H, Xiao H, Gou SJ, Herrera CA, Alba MA, Kakoki M, Falk RJ, Jennette JC. Kinin B1 Receptor Is Important in the Pathogenesis of Myeloperoxidase-Specific ANCA GN. Journal of the American Society of Nephrology : Jasn. PMID 31772138 DOI: 10.1681/Asn.2019010032 |
0.341 |
|
| 2019 |
Free ME, Stember KG, Hess JJ, McInnis EA, Lardinois O, Hogan SL, Hu Y, Mendoza C, Le AK, Guseman AJ, Pilkinton MA, Bortone DS, Cowens K, Sidney J, Karosiene E, ... ... Falk RJ, et al. Restricted myeloperoxidase epitopes drive the adaptive immune response in MPO-ANCA vasculitis. Journal of Autoimmunity. 102306. PMID 31383567 DOI: 10.1016/J.Jaut.2019.102306 |
0.77 |
|
| 2019 |
Hogan SL, Nachman PH, Poulton CJ, Hu Y, Blazek LN, Free ME, Jennette JC, Falk RJ. Understanding Long-term Remission Off Therapy in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Kidney International Reports. 4: 551-560. PMID 30993230 DOI: 10.1016/J.Ekir.2019.01.004 |
0.738 |
|
| 2019 |
Lardinois OM, Deterding LJ, Hess JJ, Poulton CJ, Henderson CD, Jennette JC, Nachman PH, Falk RJ. Immunoglobulins G from patients with ANCA-associated vasculitis are atypically glycosylated in both the Fc and Fab regions and the relation to disease activity. Plos One. 14: e0213215. PMID 30818380 DOI: 10.1371/Journal.Pone.0213215 |
0.391 |
|
| 2019 |
Stember K, McInnis E, Hogan S, Hu Y, Pilkinton M, Bortone D, Peters B, James E, Kwok W, Vincent B, Mallal S, Jennette C, Ciavatta D, Falk R, Free M. 191. CRITICAL MPO EPITOPES DRIVE THE CD4+ T CELL RESPONSE IN MPO-ANCA VASCULITIS Rheumatology. 58. DOI: 10.1093/Rheumatology/Kez061.005 |
0.735 |
|
| 2018 |
Mariani LH, Bomback AS, Canetta PA, Flessner MF, Helmuth M, Hladunewich MA, Hogan JJ, Kiryluk K, Nachman PH, Nast CC, Rheault MN, Rizk DV, Trachtman H, Wenderfer SE, Bowers C, ... ... Falk RJ, et al. CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 30420158 DOI: 10.1053/J.Ajkd.2018.07.020 |
0.319 |
|
| 2018 |
Alba MA, Jennette JC, Falk RJ. Pathogenesis of ANCA-Associated Pulmonary Vasculitis. Seminars in Respiratory and Critical Care Medicine. 39: 413-424. PMID 30404109 DOI: 10.1055/S-0038-1673386 |
0.374 |
|
| 2018 |
McCall AS, Bhave G, Pedchenko V, Hess J, Free M, Little DJ, Baker TP, Pendergraft WF, Falk RJ, Olson SW, Hudson BG. Inhibitory Anti-Peroxidasin Antibodies in Pulmonary-Renal Syndromes. Journal of the American Society of Nephrology : Jasn. PMID 30279272 DOI: 10.1681/Asn.2018050519 |
0.766 |
|
| 2018 |
Wu EY, Hernandez ML, Jennette JC, Falk RJ. Eosinophilic Granulomatosis with Polyangiitis: Clinical Pathology Conference and Review. The Journal of Allergy and Clinical Immunology. in Practice. 6: 1496-1504. PMID 30197069 DOI: 10.1016/J.Jaip.2018.07.001 |
0.316 |
|
| 2017 |
Alba MA, Flores-Suárez LF, Henderson AG, Hong X, Hu P, Nachman PH, Falk RJ, Charles Jennette J. Interstital lung disease in ANCA vasculitis. Autoimmunity Reviews. PMID 28479484 DOI: 10.1016/J.Autrev.2017.05.008 |
0.349 |
|
| 2017 |
Brown LC, Jobson MA, Payan Schober F, Chang EH, Falk RJ, Nachman PH, Pendergraft WF. The Evolving Role of Rituximab in Adult Minimal Change Glomerulopathy. American Journal of Nephrology. 45: 365-372. PMID 28315862 DOI: 10.1159/000464475 |
0.63 |
|
| 2016 |
Merkel PA, Xie G, Monach PA, Ji X, Ciavatta DJ, Byun J, Pinder BD, Zhao A, Zhang J, Tadesse Y, Qian D, Weirauch M, Nair R, Tsoi A, Pagnoux C, ... ... Falk RJ, et al. Identification of functional and expression polymorphisms associated with risk for anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Arthritis & Rheumatology (Hoboken, N.J.). PMID 28029757 DOI: 10.1002/Art.40034 |
0.331 |
|
| 2016 |
Jones BE, Yang J, Muthigi A, Hogan SL, Hu Y, Starmer J, Henderson CD, Poulton CJ, Brant EJ, Pendergraft WF, Jennette JC, Falk RJ, Ciavatta DJ. Gene-Specific DNA Methylation Changes Predict Remission in Patients with ANCA-Associated Vasculitis. Journal of the American Society of Nephrology : Jasn. PMID 27821628 DOI: 10.1681/Asn.2016050548 |
0.654 |
|
| 2016 |
Yang J, Ge H, Poulton CJ, Hogan SL, Hu Y, Jones BE, Henderson CD, McInnis EA, Pendergraft WF, Jennette JC, Falk RJ, Ciavatta DJ. Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Clinical Epigenetics. 8: 85. PMID 27752292 DOI: 10.1186/S13148-016-0251-0 |
0.694 |
|
| 2016 |
Free ME, Falk RJ. The Search for a Biomarker of Relapse in ANCA-Associated Vasculitis. Journal of the American Society of Nephrology : Jasn. PMID 27160405 DOI: 10.1681/Asn.2016030347 |
0.738 |
|
| 2016 |
Rhee RL, Hogan SL, Poulton CJ, McGregor JA, Landis JR, Falk RJ, Merkel PA. Trends in long-term outcomes among patients with ANCA-associated vasculitis with renal disease. Arthritis & Rheumatology (Hoboken, N.J.). PMID 26814428 DOI: 10.1002/Art.39614 |
0.31 |
|
| 2015 |
Jobson MA, Hogan SL, Maxwell CS, Hu Y, Hladik GA, Falk RJ, Beuhler MC, Pendergraft WF. Clinical Features of Reported Ethylene Glycol Exposures in the United States. Plos One. 10: e0143044. PMID 26566024 DOI: 10.1371/Journal.Pone.0143044 |
0.634 |
|
| 2015 |
Bunch DO, Mendoza CE, Aybar LT, Kotzen ES, Colby KR, Hu Y, Hogan SL, Poulton CJ, Schmitz JL, Falk RJ, Nachman PH, Pendergraft WF, McGregor JG. Gleaning relapse risk from B cell phenotype: decreased CD5+ B cells portend a shorter time to relapse after B cell depletion in patients with ANCA-associated vasculitis. Annals of the Rheumatic Diseases. PMID 25934841 DOI: 10.1136/Annrheumdis-2014-206756 |
0.666 |
|
| 2015 |
Reynolds J, Preston GA, Pressler BM, Hewins P, Brown M, Roth A, Alderman E, Bunch D, Jennette JC, Cook HT, Falk RJ, Pusey CD. Autoimmunity to the alpha 3 chain of type IV collagen in glomerulonephritis is triggered by 'autoantigen complementarity'. Journal of Autoimmunity. 59: 8-18. PMID 25841937 DOI: 10.1016/J.Jaut.2015.01.003 |
0.663 |
|
| 2015 |
McGregor JG, Negrete-Lopez R, Poulton CJ, Kidd JM, Katsanos SL, Goetz L, Hu Y, Nachman PH, Falk RJ, Hogan SL. Adverse events and infectious burden, microbes and temporal outline from immunosuppressive therapy in antineutrophil cytoplasmic antibody-associated vasculitis with native renal function. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 30: i171-81. PMID 25805747 DOI: 10.1093/Ndt/Gfv045 |
0.357 |
|
| 2015 |
McGregor JG, Hogan SL, Kotzen ES, Poulton CJ, Hu Y, Negrete-Lopez R, Kidd JM, Katsanos SL, Bunch DO, Nachman PH, Falk RJ. Rituximab as an immunosuppressant in antineutrophil cytoplasmic antibody-associated vasculitis. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 30: i123-31. PMID 25805743 DOI: 10.1093/Ndt/Gfv076 |
0.322 |
|
| 2015 |
Chang EH, Gasim AH, Kerber ML, Patel JB, Glaubiger SA, Falk RJ, Jennette JC, Otey CA. Palladin is upregulated in kidney disease and contributes to epithelial cell migration after injury. Scientific Reports. 5: 7695. PMID 25573828 DOI: 10.1038/Srep07695 |
0.328 |
|
| 2015 |
Jennette JC, Falk RJ. ANCAs are also antimonocyte cytoplasmic autoantibodies. Clinical Journal of the American Society of Nephrology : Cjasn. 10: 4-6. PMID 25516916 DOI: 10.2215/Cjn.11501114 |
0.322 |
|
| 2015 |
Cao Y, Liu K, Tian Z, Hogan SL, Yang J, Poulton CJ, Falk RJ, Li W. PTPN22 R620W polymorphism and ANCA disease risk in white populations: a metaanalysis. The Journal of Rheumatology. 42: 292-9. PMID 25448792 DOI: 10.3899/Jrheum.131430 |
0.351 |
|
| 2015 |
Pendergraft WF, Falk RJ. Understanding the role of rituximab in ANCA GN: regressing toward the mean. Journal of the American Society of Nephrology : Jasn. 26: 771-4. PMID 25381425 DOI: 10.1681/Asn.2014100997 |
0.679 |
|
| 2015 |
McInnis EA, Badhwar AK, Muthigi A, Lardinois OM, Allred SC, Yang J, Free ME, Jennette JC, Preston GA, Falk RJ, Ciavatta DJ. Dysregulation of autoantigen genes in ANCA-associated vasculitis involves alternative transcripts and new protein synthesis. Journal of the American Society of Nephrology : Jasn. 26: 390-9. PMID 25060059 DOI: 10.1681/Asn.2013101092 |
0.754 |
|
| 2015 |
Mistry A, Robson J, Hogan SL, Poulton C, Hu Y, Falk R, Luqmani R. Cardiovascular Outcomes Are Worse In Microscopic Polyangiitis Compared With Granulomatosis With Polyangiitis: Data From An Inception Cohort Of Patients With Anti-Neutrophil Cytoplasm Antibody Associated Systemic Vasculitis Rheumatology. 54: 169-169. DOI: 10.1093/Rheumatology/Kev090.073 |
0.351 |
|
| 2014 |
Jennette JC, Falk RJ. Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease. Nature Reviews. Rheumatology. 10: 463-73. PMID 25003769 DOI: 10.1038/Nrrheum.2014.103 |
0.362 |
|
| 2014 |
Jennette JC, Falk RJ. B cell-mediated pathogenesis of ANCA-mediated vasculitis. Seminars in Immunopathology. 36: 327-38. PMID 24777746 DOI: 10.1007/S00281-014-0431-Y |
0.38 |
|
| 2014 |
Xiao H, Dairaghi DJ, Powers JP, Ertl LS, Baumgart T, Wang Y, Seitz LC, Penfold ME, Gan L, Hu P, Lu B, Gerard NP, Gerard C, Schall TJ, Jaen JC, ... Falk RJ, et al. C5a receptor (CD88) blockade protects against MPO-ANCA GN. Journal of the American Society of Nephrology : Jasn. 25: 225-31. PMID 24179165 DOI: 10.1681/Asn.2013020143 |
0.313 |
|
| 2014 |
Joy MS, Frye RF, Nolin TD, Roberts BV, La MK, Wang J, Brouwer KL, Dooley MA, Falk RJ. In vivo alterations in drug metabolism and transport pathways in patients with chronic kidney diseases. Pharmacotherapy. 34: 114-22. PMID 24038489 DOI: 10.1002/Phar.1347 |
0.318 |
|
| 2014 |
Roncone D, Rovin B, Falk R, Nicely C, Nadasdy T, Parikh S, Hebert LA. Unexplained severe acute kidney injury with rapid recovery of kidney function 11 months later after the start of high-dose steroid therapy. Clinical Nephrology. 82: 138-142. PMID 23380388 DOI: 10.5414/Cn107643 |
0.325 |
|
| 2013 |
Free ME, Bunch DO, McGregor JA, Jones BE, Berg EA, Hogan SL, Hu Y, Preston GA, Jennette JC, Falk RJ, Su MA. Patients with antineutrophil cytoplasmic antibody-associated vasculitis have defective Treg cell function exacerbated by the presence of a suppression-resistant effector cell population. Arthritis and Rheumatism. 65: 1922-33. PMID 23553415 DOI: 10.1002/Art.37959 |
0.779 |
|
| 2013 |
Roth AJ, Ooi JD, Hess JJ, van Timmeren MM, Berg EA, Poulton CE, McGregor J, Burkart M, Hogan SL, Hu Y, Winnik W, Nachman PH, Stegeman CA, Niles J, Heeringa P, ... ... Falk RJ, et al. Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis. The Journal of Clinical Investigation. 123: 1773-83. PMID 23549081 DOI: 10.1172/Jci65292 |
0.697 |
|
| 2013 |
Free ME, Ciavatta DJ, Falk RJ. L26. How antigens influence the disease: an immunologist point of view. Presse MéDicale (Paris, France : 1983). 42: 577-9. PMID 23454000 DOI: 10.1016/J.Lpm.2013.01.026 |
0.735 |
|
| 2013 |
Jennette JC, Falk RJ, Hu P, Xiao H. Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis. Annual Review of Pathology. 8: 139-60. PMID 23347350 DOI: 10.1146/Annurev-Pathol-011811-132453 |
0.348 |
|
| 2013 |
Bunch DO, McGregor JG, Khandoobhai NB, Aybar LT, Burkart ME, Hu Y, Hogan SL, Poulton CJ, Berg EA, Falk RJ, Nachman PH. Decreased CD5⁺ B cells in active ANCA vasculitis and relapse after rituximab. Clinical Journal of the American Society of Nephrology : Cjasn. 8: 382-91. PMID 23293123 DOI: 10.2215/Cjn.03950412 |
0.329 |
|
| 2013 |
Roth A, Ooi J, Hess J, Van Timmeren M, Berg E, Poulton C, Mcgregor J, Burkart M, Hogan S, Hu Y, Winnik W, Nachman P, Stegeman C, Niles J, Heeringa P, ... ... Falk R, et al. ANCA epitope specificity determines pathogenicity, detectability and clinical predictive value La Presse MéDicale. 42: 664. DOI: 10.1016/J.Lpm.2013.02.033 |
0.755 |
|
| 2013 |
Free M, Bunch D, Mcgregor J, Poulton C, Jones B, Berg E, Hogan S, Hu Y, Preston G, Jennette C, Falk R, Su M. ANCA disease patients have defective Treg function exacerbated by expansion of a suppression-resistant effector population La Presse MéDicale. 42: 656. DOI: 10.1016/J.Lpm.2013.02.015 |
0.722 |
|
| 2012 |
Lionaki S, Blyth ER, Hogan SL, Hu Y, Senior BA, Jennette CE, Nachman PH, Jennette JC, Falk RJ. Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis. Arthritis and Rheumatism. 64: 3452-62. PMID 23023777 DOI: 10.1002/Art.34562 |
0.363 |
|
| 2012 |
Cao Y, Yang J, Colby K, Hogan SL, Hu Y, Jennette CE, Berg EA, Zhang Y, Jennette JC, Falk RJ, Preston GA. High basal activity of the PTPN22 gain-of-function variant blunts leukocyte responsiveness negatively affecting IL-10 production in ANCA vasculitis. Plos One. 7: e42783. PMID 22880107 DOI: 10.1371/Journal.Pone.0042783 |
0.32 |
|
| 2012 |
McGregor JG, Hogan SL, Hu Y, Jennette CE, Falk RJ, Nachman PH. Glucocorticoids and relapse and infection rates in anti-neutrophil cytoplasmic antibody disease. Clinical Journal of the American Society of Nephrology : Cjasn. 7: 240-7. PMID 22134625 DOI: 10.2215/Cjn.05610611 |
0.357 |
|
| 2012 |
Roth AJ, Brown MC, Smith RN, Badhwar AK, Parente O, Chung Hc, Bunch DO, McGregor JG, Hogan SL, Hu Y, Yang JJ, Berg EA, Niles J, Jennette JC, Preston GA, ... Falk RJ, et al. Anti-LAMP-2 antibodies are not prevalent in patients with antineutrophil cytoplasmic autoantibody glomerulonephritis. Journal of the American Society of Nephrology : Jasn. 23: 545-55. PMID 22021709 DOI: 10.1681/Asn.2011030273 |
0.676 |
|
| 2011 |
Roth AJ, Falk RJ. Autoantibodies: what's in their teeth? Journal of the American Society of Nephrology : Jasn. 22: 1783-4. PMID 21903994 DOI: 10.1681/Asn.2011080836 |
0.638 |
|
| 2011 |
Preston G, Falk R. Autoimmunity: Does autoantigen complementarity underlie PR3-ANCA AAV? Nature Reviews. Rheumatology. 7: 439-40. PMID 21670769 DOI: 10.1038/Nrrheum.2011.86 |
0.364 |
|
| 2011 |
Cao Y, Schmitz JL, Yang J, Hogan SL, Bunch D, Hu Y, Jennette CE, Berg EA, Arnett FC, Jennette JC, Falk RJ, Preston GA. DRB1*15 allele is a risk factor for PR3-ANCA disease in African Americans. Journal of the American Society of Nephrology : Jasn. 22: 1161-7. PMID 21617122 DOI: 10.1681/Asn.2010101058 |
0.313 |
|
| 2011 |
Ciavatta D, Falk RJ. Epigenetics and complementary proteins. Clinical and Experimental Immunology. 17-9. PMID 21447125 DOI: 10.1111/J.1365-2249.2011.04360.X |
0.335 |
|
| 2011 |
Jennette JC, Xiao H, Falk R, Gasim AMH. Experimental models of vasculitis and glomerulonephritis induced by antineutrophil cytoplasmic autoantibodies. Contributions to Nephrology. 169: 211-220. PMID 21252521 DOI: 10.1159/000314776 |
0.396 |
|
| 2011 |
Hewins P, Belmonte F, Charles Jennette J, Falk RJ, Preston GA. Longitudinal studies of patients with ANCA vasculitis demonstrate concurrent reactivity to complementary PR3 protein segments cPR3m and cPR3C and with no reactivity to cPR3N. Autoimmunity. 44: 98-106. PMID 20712431 DOI: 10.3109/08916934.2010.491843 |
0.39 |
|
| 2010 |
Jennette JC, Falk RJ. The rise and fall of horror autotoxicus and forbidden clones. Kidney International. 78: 533-5. PMID 20805814 DOI: 10.1038/Ki.2010.237 |
0.368 |
|
| 2010 |
Ciavatta DJ, Yang J, Preston GA, Badhwar AK, Xiao H, Hewins P, Nester CM, Pendergraft WF, Magnuson TR, Jennette JC, Falk RJ. Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis Journal of Clinical Investigation. 120: 3209-3219. PMID 20714105 DOI: 10.1172/Jci40034 |
0.666 |
|
| 2010 |
Falk RJ, Jennette JC. Rituximab in ANCA-associated disease. The New England Journal of Medicine. 363: 285-6. PMID 20647204 DOI: 10.1056/Nejme1004992 |
0.368 |
|
| 2010 |
Free ME, Falk RJ. IL-17A in experimental glomerulonephritis: where does it come from? Journal of the American Society of Nephrology : Jasn. 21: 885-6. PMID 20466743 DOI: 10.1681/Asn.2010040408 |
0.698 |
|
| 2010 |
Falk RJ, Jennette JC. ANCA disease: where is this field heading? Journal of the American Society of Nephrology : Jasn. 21: 745-52. PMID 20395376 DOI: 10.1681/Asn.2009121238 |
0.328 |
|
| 2010 |
Joy MS, Frye RF, Stubbert K, Brouwer KR, Falk RJ, Kharasch ED. Use of enantiomeric bupropion and hydroxybupropion to assess CYP2B6 activity in glomerular kidney diseases. Journal of Clinical Pharmacology. 50: 714-20. PMID 20103693 DOI: 10.1177/0091270009353031 |
0.317 |
|
| 2009 |
Joy MS, Dornbrook-Lavender K, Blaisdell J, Hilliard T, Boyette T, Hu Y, Hogan SL, Candiani C, Falk RJ, Goldstein JA. CYP2C9 genotype and pharmacodynamic responses to losartan in patients with primary and secondary kidney diseases. European Journal of Clinical Pharmacology. 65: 947-53. PMID 19669737 DOI: 10.1007/S00228-009-0707-7 |
0.308 |
|
| 2009 |
Lionaki S, Hogan SL, Jennette CE, Hu Y, Hamra JB, Jennette JC, Falk RJ, Nachman PH. The clinical course of ANCA small-vessel vasculitis on chronic dialysis. Kidney International. 76: 644-51. PMID 19536079 DOI: 10.1038/Ki.2009.218 |
0.329 |
|
| 2009 |
Kshirsagar AV, Craig RG, Moss KL, Beck JD, Offenbacher S, Kotanko P, Klemmer PJ, Yoshino M, Levin NW, Yip JK, Almas K, Lupovici EM, Usvyat LA, Falk RJ. Periodontal disease adversely affects the survival of patients with end-stage renal disease. Kidney International. 75: 746-51. PMID 19165177 DOI: 10.1038/Ki.2008.660 |
0.323 |
|
| 2008 |
Pagnoux C, Hogan SL, Chin H, Jennette JC, Falk RJ, Guillevin L, Nachman PH. Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: comparison of two independent cohorts. Arthritis and Rheumatism. 58: 2908-18. PMID 18759282 DOI: 10.1002/Art.23800 |
0.344 |
|
| 2008 |
Bautz DJ, Preston GA, Lionaki S, Hewins P, Wolberg AS, Yang JJ, Hogan SL, Chin H, Moll S, Jennette JC, Falk RJ. Antibodies with dual reactivity to plasminogen and complementary PR3 in PR3-ANCA vasculitis. Journal of the American Society of Nephrology : Jasn. 19: 2421-9. PMID 18701607 DOI: 10.1681/Asn.2008030270 |
0.79 |
|
| 2008 |
Bunch DO, Silver JS, Majure MC, Sullivan P, Alcorta DA, Chin H, Hogan SL, Lindstrom YI, Clarke SH, Falk RJ, Nachman PH. Maintenance of tolerance by regulation of anti-myeloperoxidase B cells. Journal of the American Society of Nephrology : Jasn. 19: 1763-73. PMID 18650487 DOI: 10.1681/Asn.2007030382 |
0.311 |
|
| 2008 |
Yang J, Bautz DJ, Lionaki S, Hogan SL, Chin H, Tisch RM, Schmitz JL, Pressler BM, Jennette JC, Falk RJ, Preston GA. ANCA patients have T cells responsive to complementary PR-3 antigen. Kidney International. 74: 1159-69. PMID 18596726 DOI: 10.1038/Ki.2008.309 |
0.789 |
|
| 2008 |
Mattoon D, Smith M, Brodey M, Chen G, Alcorta D, Patel D, Falk R, Schweitzer B. Sa.27. Discovery of SLE Autoantibody Biomarkers Utilizing Protein Microarray Technology Clinical Immunology. 127: S89. DOI: 10.1016/J.Clim.2008.03.248 |
0.304 |
|
| 2007 |
Farrag L, Pendergraft WF, Yang JJ, Jennette JC, Falk RJ, Preston GA. A study of conformational restraints on reactivity of human PR3-specific autoantibodies (ANCA) facilitated through protein folding manipulations of a new recombinant proteinase 3 protein. Autoimmunity. 40: 503-11. PMID 17966040 DOI: 10.1080/08916930701680104 |
0.678 |
|
| 2007 |
Lionaki S, Jennette JC, Falk RJ. Anti-neutrophil cytoplasmic (ANCA) and anti-glomerular basement membrane (GBM) autoantibodies in necrotizing and crescentic glomerulonephritis. Seminars in Immunopathology. 29: 459-74. PMID 17943286 DOI: 10.1007/S00281-007-0093-0 |
0.383 |
|
| 2007 |
Kshirsagar AV, Craig RG, Beck JD, Moss K, Offenbacher S, Kotanko P, Yoshino M, Levin NW, Yip JK, Almas K, Lupovici E, Falk RJ. Severe periodontitis is associated with low serum albumin among patients on maintenance hemodialysis therapy. Clinical Journal of the American Society of Nephrology : Cjasn. 2: 239-44. PMID 17699419 DOI: 10.2215/Cjn.02420706 |
0.317 |
|
| 2007 |
Lionaki S, Hogan SL, Falk RJ, Joy MS, Chin H, Jennette CE, Jennette JC, Nachman PH. Association between thyroid disease and its treatment with ANCA small-vessel vasculitis: a case-control study. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 22: 3508-15. PMID 17686815 DOI: 10.1093/Ndt/Gfm493 |
0.307 |
|
| 2007 |
Lionaki S, Falk RJ. Removing antibody and preserving glomeruli in ANCA small-vessel vasculitis. Journal of the American Society of Nephrology : Jasn. 18: 1987-9. PMID 17596633 DOI: 10.1681/Asn.2007050575 |
0.381 |
|
| 2007 |
Astern JM, Pendergraft WF, Falk RJ, Jennette JC, Schmaier AH, Mahdi F, Preston GA. Myeloperoxidase interacts with endothelial cell-surface cytokeratin 1 and modulates bradykinin production by the plasma Kallikrein-Kinin system. The American Journal of Pathology. 171: 349-60. PMID 17591979 DOI: 10.2353/Ajpath.2007.060831 |
0.754 |
|
| 2007 |
Xiao H, Schreiber A, Heeringa P, Falk RJ, Jennette JC. Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies. The American Journal of Pathology. 170: 52-64. PMID 17200182 DOI: 10.2353/Ajpath.2007.060573 |
0.362 |
|
| 2007 |
Jennette JC, Falk RJ. ANCA Vasculitis Pathology Case Reviews. 12: 200-204. DOI: 10.1097/Pcr.0B013E3181557F6E |
0.346 |
|
| 2007 |
Yang J, Bautz D, Smitz J, Chin H, Pressler B, Hogan S, Tisch R, Jennette JC, Falk R, Preston G. T Cell Responsiveness to Complementary PR3 Protein Supports a Pathogenic Role of Autoantigen Complementarity in PR3-ANCA Autoimmune Disease Clinical Immunology. 123: S121. DOI: 10.1016/J.Clim.2007.03.523 |
0.774 |
|
| 2006 |
Schreiber A, Xiao H, Falk RJ, Jennette JC. Bone marrow-derived cells are sufficient and necessary targets to mediate glomerulonephritis and vasculitis induced by anti-myeloperoxidase antibodies. Journal of the American Society of Nephrology : Jasn. 17: 3355-64. PMID 17108314 DOI: 10.1681/Asn.2006070718 |
0.352 |
|
| 2006 |
Jennette JC, Xiao H, Falk RJ. Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies. Journal of the American Society of Nephrology : Jasn. 17: 1235-42. PMID 16624929 DOI: 10.1681/Asn.2005101048 |
0.414 |
|
| 2006 |
Erdbrügger U, Hellmark T, Bunch DO, Alcorta DA, Jennette JC, Falk RJ, Nachman PH. Mapping of myeloperoxidase epitopes recognized by MPO-ANCA using human-mouse MPO chimers. Kidney International. 69: 1799-805. PMID 16557221 DOI: 10.1038/Sj.Ki.5000354 |
0.311 |
|
| 2006 |
Hogan SL, Falk RJ, Nachman PH, Jennette JC. Various forms of life in antineutrophil cytoplasmic antibody-associated vasculitis. Annals of Internal Medicine. 144: 377-8; author reply . PMID 16520483 DOI: 10.7326/0003-4819-144-5-200603070-00019 |
0.309 |
|
| 2005 |
Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC, Nachman PH. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Annals of Internal Medicine. 143: 621-31. PMID 16263884 DOI: 10.7326/0003-4819-143-9-200511010-00005 |
0.31 |
|
| 2005 |
Huugen D, Xiao H, van Esch A, Falk RJ, Peutz-Kootstra CJ, Buurman WA, Tervaert JW, Jennette JC, Heeringa P. Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha. The American Journal of Pathology. 167: 47-58. PMID 15972951 DOI: 10.1016/S0002-9440(10)62952-5 |
0.323 |
|
| 2005 |
Xiao H, Heeringa P, Liu Z, Huugen D, Hu P, Maeda N, Falk RJ, Jennette JC. The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies. The American Journal of Pathology. 167: 39-45. PMID 15972950 DOI: 10.1016/S0002-9440(10)62951-3 |
0.384 |
|
| 2005 |
Preston GA, Pendergraft WF, Falk RJ. New insights that link microbes with the generation of antineutrophil cytoplasmic autoantibodies: the theory of autoantigen complementarity. Current Opinion in Nephrology and Hypertension. 14: 217-22. PMID 15821413 DOI: 10.1097/01.Mnh.0000165886.93427.B1 |
0.675 |
|
| 2005 |
Pendergraft WF, Pressler BM, Jennette JC, Falk RJ, Preston GA. Autoantigen complementarity: a new theory implicating complementary proteins as initiators of autoimmune disease. Journal of Molecular Medicine (Berlin, Germany). 83: 12-25. PMID 15592920 DOI: 10.1007/S00109-004-0615-3 |
0.704 |
|
| 2004 |
Heeringa P, Schreiber A, Falk RJ, Jennette JC. Pathogenesis of pulmonary vasculitis. Seminars in Respiratory and Critical Care Medicine. 25: 465-74. PMID 16088492 DOI: 10.1055/S-2004-836140 |
0.386 |
|
| 2004 |
Yang JJ, Pendergraft WF, Alcorta DA, Nachman PH, Hogan SL, Thomas RP, Sullivan P, Jennette JC, Falk RJ, Preston GA. Circumvention of normal constraints on granule protein gene expression in peripheral blood neutrophils and monocytes of patients with antineutrophil cytoplasmic autoantibody-associated glomerulonephritis. Journal of the American Society of Nephrology : Jasn. 15: 2103-14. PMID 15284296 DOI: 10.1097/01.Asn.0000135058.46193.72 |
0.704 |
|
| 2004 |
McCarthy ET, Sharma M, Sharma R, Falk RJ, Jennette JC. Sera from patients with collapsing focal segmental glomerulosclerosis increase albumin permeability of isolated glomeruli. The Journal of Laboratory and Clinical Medicine. 143: 225-9. PMID 15085081 DOI: 10.1016/J.Lab.2004.01.007 |
0.306 |
|
| 2004 |
Preston GA, Waga I, Alcorta DA, Sasai H, Munger WE, Sullivan P, Phillips B, Jennette JC, Falk RJ. Gene expression profiles of circulating leukocytes correlate with renal disease activity in IgA nephropathy. Kidney International. 65: 420-30. PMID 14717912 DOI: 10.1111/J.1523-1755.2004.00398.X |
0.314 |
|
| 2004 |
Pendergraft WF, Rudolph EH, Falk RJ, Jahn JE, Grimmler M, Hengst L, Jennette JC, Preston GA. Proteinase 3 sidesteps caspases and cleaves p21(Waf1/Cip1/Sdi1) to induce endothelial cell apoptosis. Kidney International. 65: 75-84. PMID 14675038 DOI: 10.1111/J.1523-1755.2004.00364.X |
0.652 |
|
| 2004 |
Pendergraft WF, Preston GA, Shah RR, Tropsha A, Carter CW, Jennette JC, Falk RJ. Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3. Nature Medicine. 10: 72-9. PMID 14661018 DOI: 10.1038/Nm968 |
0.704 |
|
| 2004 |
Higuchi T, Orita T, Nakanishi S, Katsuya K, Watanabe H, Yamasaki Y, Waga I, Nanayama T, Yamamoto Y, Munger W, Sun HW, Falk RJ, Jennette JC, Alcorta DA, Li H, et al. Molecular cloning, genomic structure, and expression analysis of MUC20, a novel mucin protein, up-regulated in injured kidney. The Journal of Biological Chemistry. 279: 1968-79. PMID 14565953 DOI: 10.1074/Jbc.M304558200 |
0.304 |
|
| 2004 |
Erdbruegger U, Dooley MA, Falk RJ. New insights into mechanisms of immune-mediated glomerular diseases Drug Discovery Today: Disease Mechanisms. 1: 73-81. DOI: 10.1016/J.Ddmec.2004.07.002 |
0.338 |
|
| 2003 |
Klemmer PJ, Chalermskulrat W, Reif MS, Hogan SL, Henke DC, Falk RJ. Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 42: 1149-53. PMID 14655185 DOI: 10.1053/J.Ajkd.2003.08.015 |
0.303 |
|
| 2003 |
Waga I, Yamamoto J, Sasai H, Munger WE, Hogan SL, Preston GA, Sun HW, Jennette JC, Falk RJ, Alcorta DA. Altered mRNA expression in renal biopsy tissue from patients with IgA nephropathy. Kidney International. 64: 1253-64. PMID 12969143 DOI: 10.1046/J.1523-1755.2003.00220.X |
0.323 |
|
| 2003 |
Segelmark M, Phillips BD, Hogan SL, Falk RJ, Jennette JC. Monitoring proteinase 3 antineutrophil cytoplasmic antibodies for detection of relapses in small vessel vasculitis. Clinical and Diagnostic Laboratory Immunology. 10: 769-74. PMID 12965902 DOI: 10.1128/Cdli.10.5.769-774.2003 |
0.354 |
|
| 2003 |
Kshirsagar AV, Nachman PH, Falk RJ. Alternative therapies and future intervention for treatment of membranous nephropathy. Seminars in Nephrology. 23: 362-72. PMID 12923724 DOI: 10.1016/S0270-9295(03)00047-0 |
0.352 |
|
| 2003 |
Franceschini N, Hogan SL, Falk RJ. Primum non nocere: Should adults with idiopathic FSGS receive steroids? Seminars in Nephrology. 23: 229-33. PMID 12704583 DOI: 10.1053/Snep.2003.50021 |
0.308 |
|
| 2003 |
Sedivá A, Bartůnková J, Bartosová J, Jennette C, Falk RJ, Jethwa HS. Antineutrophil cytoplasmic antibodies directed against bactericidal/permeability-increasing protein detected in children with cystic fibrosis inhibit neutrophil-mediated killing of Pseudomonas aeruginosa. Microbes and Infection / Institut Pasteur. 5: 27-30. PMID 12593970 DOI: 10.1016/S1286-4579(02)00049-7 |
0.347 |
|
| 2003 |
Ohlsson S, Falk R, Yang JJ, Ohlsson K, Segelmark M, Wieslander J. Increased expression of the secretory leukocyte proteinase inhibitor in Wegener's granulomatosis. Clinical and Experimental Immunology. 131: 190-196. PMID 12519404 DOI: 10.1046/J.1365-2249.2003.02024.X |
0.335 |
|
| 2002 |
Preston GA, Zarella CS, Pendergraft WF, Rudolph EH, Yang JJ, Sekura SB, Jennette JC, Falk RJ. Novel effects of neutrophil-derived proteinase 3 and elastase on the vascular endothelium involve in vivo cleavage of NF-kappaB and proapoptotic changes in JNK, ERK, and p38 MAPK signaling pathways. Journal of the American Society of Nephrology : Jasn. 13: 2840-9. PMID 12444202 DOI: 10.1097/01.Asn.0000034911.03334.C3 |
0.661 |
|
| 2002 |
Yang JJ, Preston GA, Alcorta DA, Waga I, Munger WE, Hogan SL, Sekura SB, Phillips BD, Thomas RP, Jennette JC, Falk RJ. Expression profile of leukocyte genes activated by anti-neutrophil cytoplasmic autoantibodies (ANCA). Kidney International. 62: 1638-49. PMID 12371964 DOI: 10.1046/J.1523-1755.2002.00619.X |
0.349 |
|
| 2002 |
Xiao H, Heeringa P, Hu P, Liu Z, Zhao M, Aratani Y, Maeda N, Falk RJ, Charles Jennette J. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice Journal of Clinical Investigation. 110: 955-963. PMID 12370273 DOI: 10.1172/Jci15918 |
0.3 |
|
| 2002 |
Alcorta D, Preston G, Munger W, Sullivan P, Yang JJ, Waga I, Jennette JC, Falk R. Microarray studies of gene expression in circulating leukocytes in kidney diseases. Experimental Nephrology. 10: 139-49. PMID 11937761 DOI: 10.1159/000049909 |
0.343 |
|
| 2001 |
Yang JJ, Preston GA, Pendergraft WF, Segelmark M, Heeringa P, Hogan SL, Jennette JC, Falk RJ. Internalization of proteinase 3 is concomitant with endothelial cell apoptosis and internalization of myeloperoxidase with generation of intracellular oxidants. The American Journal of Pathology. 158: 581-92. PMID 11159195 DOI: 10.1016/S0002-9440(10)64000-X |
0.676 |
|
| 2000 |
Jethwa HS, Clarke SH, Itoh-Lindstrom Y, Falk RJ, Jennette JC, Nachman PH. Restriction in Vκ gene use and antigen selection in anti-myeloperoxidase response in mice Journal of Immunology. 165: 3890-3897. PMID 11034396 DOI: 10.4049/Jimmunol.165.7.3890 |
0.32 |
|
| 2000 |
Jethwa HS, Nachman PH, Falk RJ, Jennette JC. False-positive myeloperoxidase binding activity due to DNA/anti-DNA antibody complexes: a source for analytical error in serologic evaluation of anti-neutrophil cytoplasmic autoantibodies. Clinical and Experimental Immunology. 121: 544-50. PMID 10971523 DOI: 10.1046/J.1365-2249.2000.01325.X |
0.314 |
|
| 2000 |
Yang JJ, Tuttle RH, Hogan SL, Taylor JG, Phillips BD, Falk RJ, Jennette JC. Target antigens for anti-neutrophil cytoplasmic autoantibodies (ANCA) are on the surface of primed and apoptotic but not unstimulated neutrophils. Clinical and Experimental Immunology. 121: 165-72. PMID 10886255 DOI: 10.1046/J.1365-2249.2000.01228.X |
0.319 |
|
| 2000 |
Pendergraft WF, Alcorta DA, Segelmark M, Yang JJ, Tuttle R, Jennette JC, Falk RJ, Preston GA. ANCA antigens, proteinase 3 and myeloperoxidase, are not expressed in endothelial cells. Kidney International. 57: 1981-90. PMID 10792617 DOI: 10.1046/J.1523-1755.2000.00048.X |
0.675 |
|
| 2000 |
Segelmark M, Barrett C, Pendergraft W, Falk R, Preston G. Expression of p300-truncated fragments results in the modulation of apoptosis in rat mesangial cells. Kidney International. 57: 1873-81. PMID 10792606 DOI: 10.1046/J.1523-1755.2000.00037.X |
0.656 |
|
| 2000 |
Savige J, Davies D, Falk RJ, Jennette JC, Wiik A. Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features. Kidney International. 57: 846-62. PMID 10720938 DOI: 10.1046/J.1523-1755.2000.057003846.X |
0.39 |
|
| 1999 |
Savige J, Gillis D, Benson E, Davies D, Esnault V, Falk RJ, Hagen EC, Jayne D, Jennette JC, Paspaliaris B, Pollock W, Pusey C, Savage COS, Silvestrini R, Van Der Woude F, et al. International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA) American Journal of Clinical Pathology. 111: 507-513. PMID 10191771 DOI: 10.1093/Ajcp/111.4.507 |
0.339 |
|
| 1999 |
Lim LC, Taylor JG, Schmitz JL, Folds JD, Wilkman AS, Falk RJ, Jennette JC. Diagnostic usefulness of antineutrophil cytoplasmic autoantibody serology. Comparative evaluation of commercial indirect fluorescent antibody kits and enzyme immunoassay kits. American Journal of Clinical Pathology. 111: 363-9. PMID 10078112 DOI: 10.1093/Ajcp/111.3.363 |
0.332 |
|
| 1998 |
Jethwa HS, Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic antibody (ANCA) target antigens, disease associations, and laboratory testing Clinical Immunology Newsletter. 18: 10-15. DOI: 10.1016/S0197-1859(00)89166-9 |
0.375 |
|
| 1997 |
Jennette JC, Falk RJ. Diagnosis and management of glomerular diseases. The Medical Clinics of North America. 81: 653-77. PMID 9167650 DOI: 10.1016/S0025-7125(05)70538-1 |
0.314 |
|
| 1996 |
Yang JJ, Tuttle R, Falk RJ, Jennette JC. Frequency of anti-bactericidal/permeability-increasing protein (BPI) and anti-azurocidin in patients with renal disease. Clinical and Experimental Immunology. 105: 125-31. PMID 8697620 DOI: 10.1046/J.1365-2249.1996.D01-738.X |
0.392 |
|
| 1995 |
Ewert BH, Becker ME, Jennette JC, Falk RJ. Antimyeloperoxidase antibodies induce neutrophil adherence to cultured human endothelial cells. Renal Failure. 17: 125-33. PMID 7644763 DOI: 10.3109/08860229509026249 |
0.338 |
|
| 1994 |
Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis and Rheumatism. 37: 187-92. PMID 8129773 DOI: 10.1002/Art.1780370206 |
0.328 |
|
| 1993 |
Baldree LA, Wyatt RJ, Julian BA, Falk RJ, Jennette JC. Immunoglobulin A-fibronectin aggregate levels in children and adults with immunoglobulin A nephropathy. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 22: 1-4. PMID 8322770 DOI: 10.1016/S0272-6386(12)70159-2 |
0.32 |
|
| 1992 |
Falk RJ, Scheinman J, Phillips G, Orringer E, Johnson A, Jennette JC. Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme. The New England Journal of Medicine. 326: 910-5. PMID 1542341 DOI: 10.1056/Nejm199204023261402 |
0.331 |
|
| 1992 |
Falk RJ, Becker M, Terrell R, Jennette JC. Anti-myeloperoxidase autoantibodies react with native but not denatured myeloperoxidase. Clinical and Experimental Immunology. 89: 274-8. PMID 1379133 DOI: 10.1111/J.1365-2249.1992.Tb06944.X |
0.367 |
|
| 1992 |
Ewert BH, Jennette JC, Falk RJ. Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells. Kidney International. 41: 375-83. PMID 1313124 DOI: 10.1038/Ki.1992.52 |
0.367 |
|
| 1992 |
Charles LA, Falk RJ, Jennette JC. Reactivity of antineutrophil cytoplasmic autoantibodies with mononuclear phagocytes. Journal of Leukocyte Biology. 51: 65-8. PMID 1311014 DOI: 10.1002/Jlb.51.1.65 |
0.341 |
|
| 1991 |
Jennette JC, Wieslander J, Tuttle R, Falk RJ. Serum IgA-fibronectin aggregates in patients with IgA nephropathy and Henoch-Schönlein purpura: diagnostic value and pathogenic implications. The Glomerular Disease Collaborative Network. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 18: 466-71. PMID 1928066 DOI: 10.1016/S0272-6386(12)80115-6 |
0.336 |
|
| 1991 |
Jennette JC, Falk RJ. Diagnostic classification of antineutrophil cytoplasmic autoantibody-associated vasculitides. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 18: 184-7. PMID 1867177 DOI: 10.1016/S0272-6386(12)80878-X |
0.305 |
|
| 1991 |
Jennette JC, Charles LA, Falk RJ. Antineutrophil cytoplasmic autoantibodies: disease associations, molecular biology, and pathophysiology. International Review of Experimental Pathology. 32: 193-221. PMID 1677932 DOI: 10.1016/B978-0-12-364932-4.50009-5 |
0.314 |
|
| 1991 |
Charles LA, Caldas ML, Falk RJ, Terrell RS, Jennette JC. Antibodies against granule proteins activate neutrophils in vitro. Journal of Leukocyte Biology. 50: 539-46. PMID 1658170 DOI: 10.1002/Jlb.50.6.539 |
0.364 |
|
| 1991 |
Ewert BH, Jennette JC, Falk RJ. The pathogenic role of antineutrophil cytoplasmic autoantibodies. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 18: 188-95. PMID 1651049 DOI: 10.1016/S0272-6386(12)80879-1 |
0.409 |
|
| 1990 |
Falk RJ, Hogan S, Carey TS, Jennette JC. Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network. Annals of Internal Medicine. 113: 656-63. PMID 2221646 DOI: 10.7326/0003-4819-113-9-656 |
0.382 |
|
| 1990 |
Falk RJ, Terrell RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proceedings of the National Academy of Sciences of the United States of America. 87: 4115-9. PMID 2161532 DOI: 10.1073/Pnas.87.11.4115 |
0.34 |
|
| 1990 |
Jennette JC, Falk RJ. Antineutrophil cytoplasmic autoantibodies and associated diseases: a review. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 15: 517-29. PMID 1973331 DOI: 10.1016/S0272-6386(12)80521-X |
0.403 |
|
| 1990 |
Falk RJ, Jennette J. Antineutrophil cytoplasmic autoantibody in renal disease Clinical Immunology Newsletter. 10: 166-170. DOI: 10.1016/0197-1859(90)90011-V |
0.335 |
|
| 1989 |
Dalmasso AP, Falk RJ, Raij L. The pathobiology of the terminal complement complexes. Complement and Inflammation. 6: 36-48. PMID 2650989 DOI: 10.1159/000463070 |
0.358 |
|
| 1989 |
Charles LA, Falk RJ, Jennette JC. Reactivity of anti-neutrophil cytoplasmic autoantibodies with HL-60 cells. Clinical Immunology and Immunopathology. 53: 243-53. PMID 2551551 DOI: 10.1016/0090-1229(89)90054-8 |
0.377 |
|
| 1989 |
Finn AL, Tsai LM, Falk RJ. Monoclonal antibodies to the apical chloride channel in Necturus gallbladder inhibit the chloride conductance. Proceedings of the National Academy of Sciences of the United States of America. 86: 7649-52. PMID 2477847 DOI: 10.1073/Pnas.86.19.7649 |
0.318 |
|
| 1988 |
Specks U, Rohrbach MS, DeRemee RA, Jennette JC, Falk RJ. Anti-neutrophil cytoplasmic autoantibodies. The New England Journal of Medicine. 319: 1416-1417. PMID 3185657 DOI: 10.1056/Nejm198811243192114 |
0.327 |
|
| 1988 |
Falk RJ, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. The New England Journal of Medicine. 318: 1651-7. PMID 2453802 DOI: 10.1056/NEJM198806233182504 |
0.308 |
|
| 1987 |
Woodley DT, Ernst T, Reese MJ, Ogden NM, Gammon WR, Briggaman RA, Falk RJ. Neonatal foreskin substrate has limitations for the immunofluorescent screening of monoclonal antibodies. The Journal of Investigative Dermatology. 88: 167-71. PMID 3543143 DOI: 10.1111/1523-1747.Ep12525308 |
0.317 |
|
| 1985 |
Falk RJ, Dalmasso AP, Kim Y, Lam S, Michael A. Radioimmunoassay of the attack complex of complement in serum from patients with systemic lupus erythematosus. The New England Journal of Medicine. 312: 1594-9. PMID 4000197 DOI: 10.1056/Nejm198506203122502 |
0.335 |
|
| Show low-probability matches. |